It is our aspiration to engineer the medicines of tomorrow and our employees are crucial to our success. In an industry such as biotechnology, where success largely depends on the innovation capability and commitment of staff, aspects such as employee attraction, retention and employee satisfaction are decisive factors. Close cooperation across disciplines and geographies is key to achieving our goals. Our Human Resources (HR) department manages all topics related to employer attractiveness, diversity and equal opportunities. Our Health and Safety department, integrated into the Technical Operations area, takes care of all aspects of occupational health and safety (OHS).
The transition of MorphoSys from a monoclonal antibody specialist to a fully integrated biopharmaceutical company required additional, complementary skill sets across various disciplines. This includes clinical development execution, building out a commercial infrastructure along with medical affairs, regulatory and policy in order to bring the therapy to healthcare providers and patients in need. Steady growth, with our workforce almost doubling since the end of 2018 to 6151 employees at the end of 2020, requires appropriate measures to attract and retain the right employees. We achieve this by focusing on the needs of patients and committing to our Company values – Courage, Urgency, Innovation and Collaboration – in everything we do.
1 Released employees, trainees and employees on parental leave are not included.
Focus in 2020
We initiated several projects in 2020 to set up our Company organizationally and culturally for our growth. We defined a new global operating model based on a lean structure, built a U.S. organization and set up processes and frameworks that contribute to a culture of continuous performance excellence.
As part of our new way of working, we realigned the leadership organization by launching an Executive Committee in addition to the Management Board. The Committee consists of the Management Board members and four additional executives from legal, business development, HR and technical operations to ensure inclusive decision-making along the whole value chain. This management team is composed by a diverse group of individuals comprising gender, nationality, professional background and industry knowledge.
In addition, a Global Leadership Group including approximately 80 top executives from various departments was introduced at our sites in Germany and the U.S. to demonstrate an environment of dialogue across the Company. It is paramount to MorphoSys to be attractive by creating a culture of collaboration and inclusion of different perspectives.
As we need to continue to look for the best talent during this time of growth, we initiated new employer branding campaigns, with special focus on commercial and clinical development. In 2020 we successfully built our new U.S. commercial organization and started to build a new clinical development hub in Boston, while we continued to expand our headquarters’ corporate and R&D functions. We increased our social media presence by relaunching our employer messaging on LinkedIn as well as deploying new content on our corporate and U.S. career website. We are committed to transparency about our job opportunities, current and expected skills and capabilities of our employees, as well as the working environment which we offer to applicants across the world.
With these measures, we consider ourselves well on the way to coping with the Company’s growth.